Showing results (131-140 of 148) with videos related to
Sort By:
Pageof 15
The Oncologist|March 25, 2016
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C Kadakia, Claire F Snyder, Kelley M Kidwell, et al.Annals of Internal Medicine|November 23, 2006
Pharmacogenomics: challenges and opportunitiesDan M Roden, Russ B Altman, Neal L Benowitz, et al.Clinical and Translational Science|June 29, 2011
Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in PregnancyDavid M Haas, Beverly Gallauresi, Kristine Shields, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trialsMatthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.Breast Cancer Research and Treatment|November 6, 2015
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnoverSteffi Oesterreich, N Lynn Henry, Kelley M Kidwell, et al.Journal of the National Cancer Institute|January 6, 2005
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatmentYan Jin, Zeruesenay Desta, Vered Stearns, et al.Cancer Discovery|June 15, 2013
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer preventionJames N Ingle, Mohan Liu, D Lawrence Wickerham, et al.Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitorsJames N Ingle, Daniel J Schaid, Paul E Goss, et al.Pageof 15